| Symbol | Description |
Total
|
|---|---|---|
| ABT | ABBOTT LABORATORIES | $3,000.00 |
| APD | AIR PRODS & CHEMS INC | $2,500.00 |
| HD | HOME DEPOT INC | $3,000.00 |
| HRL | HORMEL FOODS CORP | $800.00 |
| NKE | NIKE INC CL B | $1,800.00 |
| PM | PHILIP MORRIS INTL INC COM | $800.00 |
| T | AT&T INC | $800.00 |
Today I also swapped AbbVie (ABBV) in exchange for its parent company Abbott Labs (ABT). Note that Abbott in the past spun off AbbVie so shareholders in Abbott got both shares in AbbVie and Abbott. I prefer Abbott's stable medical device business, nutritional food items, and diagnostics products instead of the more uncertain AbbVie pharma products and AbbVie's high reliance on their one hit wonder drug Humira (and the expiring patent rights). AbbVie has the potential for more capital appreciation but comes with more risk. I don't feel that I need to take such risks to achieve my goals so I am performing this swap. I am not very fond of hoping that AbbVie management is capable of continuously pumping out one hit wonder drugs from their pipelines and prefer straight forward simple boring companies. AbbVie occupied less than 2% of my portfolio and my net return including dividends was around -$3.00 which includes trade commissions, so it was basically flat.
The above chunk of buys averages around 2.54% yield so that is about $312 more per year in dividends.
That's a lot of buys. Nice to see the "high" market conditions are not scaring you away from continuing to build up your positions. I still like ABBV and will continue to hold but I understand your concerns about having to continually come up with awesome new drugs every few years. HRL look like a solid consumer staple I could get behind. It's my favorite sector. Thanks for sharing.
ReplyDelete